Nuclear Medicine Market is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period

 


The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period. Nuclear medicine may be a medicine involving the appliance of radioactive substances within the diagnosis and treatment of disease. Medicine imaging, during a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body instead of radiation that's generated by external sources like X-rays. Additionally, medicine scans differ from radiology, because the emphasis isn't on imaging anatomy, but on the function. For such reason, it's called a physiological imaging modality. Single photon emission computerized tomography (SPECT) and positron emission tomography (PET) scans are the 2 commonest imaging modalities in medicine.

 

The report " Global Nuclear Medicine Market, By Diagnostics (Single Photon Emission, Computed Tomography (SPECT), and Positron Emission Tomography (PET)), By Therapeutics (Alpha Emitters, Beta Emitters, and Brachytherapy), By Applications (Cardiology, Neurology, Oncology, and Other Applications), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

 

Key Highlights:

·         In 2021, Penn Medicine’s clinical, operational, and research and clinical capabilities, the health system is launching the Center for Applied Health Informatics to better facilitate and coordinate health data projects across the health system and grow its leadership in health informatics globally.

·         In 2021, Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) announced that its subsidiary, EXINI Diagnostics AB, was granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its digital application, aPROMISE™ (automated PROstate Cancer Molecular Imaging Standardized Evaluation).

 

Analyst View:

Nuclear medicine shows a huge potential in treating cardiac and cancer diseases. Several factors are poised to augment the demand for nuclear medicine, but none bigger than the growing prevalence of cancer and cardiac disorders. Advances in radiotracers, the advent of alpha radioimmunotherapy (Rit)-based targeted cancer treatments, and investments via public and private partnerships to revolutionize diagnostic measures are some of the other factors expected to drive the demand for the target market shortly.

 

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3827

 

Key Market Insights from the report:

The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period. The nuclear medicine market is segmented by diagnostics, by therapeutics, by applications, and by regions.

·         On the basis of Diagnostics, the Global Nuclear Medicine Market is segmented into Single Photon Emission, Computed Tomography (SPECT), and Positron Emission Tomography (PET).

·         On the basis of Therapeutics, the target market is segmented into Alpha Emitters, Beta Emitters, and Brachytherapy.

·         Based on Applications, the global market is classified into Cardiology, Neurology, Oncology, and Other Applications.

·         Based on region the Global Nuclear Medicine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global market in North America region is seen to have a matured growth since this market correlates with the increasing growth rate of cancer.

Competitive Landscape:

The key players operating the global nuclear medicine market involves Eckert & Ziegler Group, Mallinckrodt Pharmaceuticals, GE Healthcare; Jubilant Life Sciences; Bracco Imaging S.p.A, Nordion, Inc., The Institute of Radioelements, Australian Nuclear Science & Technology Organization (ANSTO), NTP Radioisotopes SOC Ltd., and Eczacibasi-Monroe.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

 

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

·         Explains an overview of the product portfolio, including product development, planning, and positioning

·         Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.

·         Detailed analysis of the market revenue over the forecasted period.

·         Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.

·         Study on the segments that are anticipated to dominate the market.

·         Study on the regional analysis that is expected to register the highest growth over the forecast period 

 

Key Topics Covered

1.       Introduction

·         Study Deliverables

·         Study Assumptions

·         Scope of the Study

2.       Research Methodology

3.       Executive Summary

·         Opportunity Map Analysis

·         Market at Glance

·         Market Share (%) and BPS Analysis, by Region

·         Competitive Landscape

·         Heat Map Analysis 

·         Market Presence and Specificity Analysis

4.       Investment Analysis

5.       Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Antibody Drug Conjugate Market is estimated to be US$ 27.0 billion by 2030 with a CAGR of 23.5% during the forecast period

Image
  Antibody drug conjugate market accounted for US$ 3.3 billion in 2020 and is estimated to be US$ 27.0 billion by 2030 and is anticipated to register a CAGR of 23.5% . Antibody-drug conjugates or ADCs are biopharmaceutical drugs designed for targeted therapy for treating various type of cancer. ADCs are expose to target and kill tumor cells while sparing healthy cells. As of now 59npharmaceutical companies developed ADCs. These are complex molecules composed of antibody and have capability to target cancer cells by discriminating healthy tissues and diseased tissues. The report "   Global Antibody Drug Conjugate Market, By Technology (Cleavable Linker and Non-Cleavable Linker), By Application (Blood Cancer, Ovarian Cancer, Lung Cancer and Brain Tumor), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”...
Read more

Inulin Market is estimated to be US$ 2.29 billion by 2030 with a CAGR of 5.5% during the forecast period

Image
  The report "Global Inulin Market , By Application (Food and Beverage, Dietary Supplements, and Pharmaceutical) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”. Increasing awareness about prebiotic ingredients and their extensive utilization in food and beverages industry is the major factor driving the growth of the global inulin market globally. Inulin has various applications in dairy product formation such as cheese, yogurts, and ice-cream. Hence, the growth in dairy industries is projected to boost additional growth in inulin market over the forecast period. Also, high growth in the pharmaceuticals industry worldwide is propelling the growth of the target market. Furthermore, the fast-growing significance of nutraceuticals due to increasing health awareness is expected to increase demand for inulin as a functional ingredient. Key Highlights: In June 2018, Cosucra’s inulin-type fru...
Read more

Intraocular Lens Market is estimated to be US$ 7.9 billion by 2032 with a CAGR of 7.2% over the forecast period (2022-2032)

Image
  The Intraocular Lenses implant is routinely utilized during cataract surgery. Intraocular Lenses work as natural lenses. Lens implant has various focusing powers like prescription contact lenses or eyeglasses. There are different types of Intraocular Lenses like – Monofocal IOLs, which has one focal point & can be set to focus on close, medium, and distance vision which is based on preference. Distance vision is the most common selection. Trifocal IOLs, help to see better in distance, computer distance, and reading distance. Trifocal IOLs help in allowing to see both the distance and near while looking in any kind of direction. Toric IOLs is used if one has significant eye astigmatism. Astigmatism result when cornea flatter in one direction like a football. Toric Intraocular Lenses are designed for correcting astigmatism and allows to have great vision without glasses. Phakic lenses are commonly used for correcting moderate to severe nearsightedness. Phakic lenses are surgic...
Read more